Legal24 Oct 2026, 12:30 pm
Sahajanand Medical Technologies Receives GST Summons
AI Summary
Sahajanand Medical Technologies Ltd has received a summons dated October 16, 2026, from the DGGI, Mumbai Zonal Unit, under Section 70 of the Central Goods and Services Tax Act, 2017. The summons is in connection with an inquiry into reimbursements made to foreign subsidiaries for clinical trials. The company stated it is fully cooperating with the authorities and that the summons does not have any material financial impact at this stage. Further significant developments will be communicated.
Key Highlights
- Received GST summons under Section 70 of CGST Act.
- Inquiry relates to reimbursements to foreign subsidiaries.
- Company is cooperating with authorities.
- No material financial impact anticipated at this stage.
Price Impact
More from SMT